AQR Arbitrage’s Translational Development Acquisition Corp TDAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.6M Sell
1,094,210
-2,779
-0.3% -$29.3K 0.19% 116
2025
Q4
$11.5M Hold
1,096,989
0.24% 107
2025
Q3
$11.3M Sell
1,096,989
-3,000
-0.3% -$31K 0.29% 117
2025
Q2
$11.3M Hold
1,099,989
0.26% 117
2025
Q1
$11.1M Buy
+1,099,989
New +$11M 0.26% 120

Other funds holding TDAC

AQR Arbitrage's TDAC Position: Q1 2026 in Review

AQR Arbitrage reduced its Translational Development Acquisition Corp (TDAC) stake by 0.25% in Q1 2026, selling an estimated $29.3K and leaving 1,094,210 shares worth $11.6M. The position accounts for 0.19% of the portfolio, ranked #116.

AQR Arbitrage first reported a position in TDAC in Q1 2025 and has held it in 5 quarters since. 48 funds tracked by Wall St. Rank hold TDAC as of Q1 2026.

  • AQR Arbitrage held 1,094,210 shares of Translational Development Acquisition Corp worth $11.6M as of Q1 2026.
  • AQR Arbitrage sold 2,779 Translational Development Acquisition Corp shares in Q1 2026, an estimated $29.3K.
  • Translational Development Acquisition Corp made up 0.19% of AQR Arbitrage's portfolio in Q1 2026, its #116 holding.
  • AQR Arbitrage first reported a position in Translational Development Acquisition Corp in Q1 2025 and has held it in 5 quarters since.
  • 48 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q1 2026.

Based on AQR Arbitrage's 13F filing for Q1 2026, filed 15 May 2026.